ASX:CSLBiotechs
A Closer Look at CSL (ASX:CSL) Valuation Following Capital Markets Day and Guidance Downgrade
CSL (ASX:CSL) is in the spotlight as it hosts its Capital Markets Day event, presenting strategic priorities and growth initiatives for investors. The timing comes after a recent guidance downgrade and market volatility.
See our latest analysis for CSL.
Despite promising long-term trends in core plasma and vaccine markets, CSL’s share price return has slid sharply this year, with a 30-day drop of 14.3% and a year-to-date fall of 37.3%. After briefly rallying on hopes for operational...